Epidemiology and Genetics Research Program Division of Cancer Control and Population Sciences January 8, 2001

News Flash

In response to a number of requests, the deadline for receipt of abstracts for the Fifth International AIDS Malignancy Conference is extended to February 27, 2001. This extension was made possible by changing the way the abstracts will be published. A tumor virology component to the meeting, as described below, has also been added.

The Fifth International Aids Malignancy Conference
Natcher Conference Center, National Institutes of Health (NIH) Campus
Bethesda, Maryland
April 23-25, 2001

The National Cancer Institute (NCI) is sponsoring the fifth conference on malignancies in AIDS and other types of immune deficiencies on April 23-25, 2001, at the Natcher Conference Center, National Institutes of Health (NCI) Campus, Bethesda, Md. The objectives are to share state-of-the art clinical research, epidemiologic research, and basic research results in order to advance research across diverse disciplines. This year's program will incorporate more basic research on the role of viruses, particularly human papillomavirus (HPV), Epstein-Barr Virus (EBV), and Kaposi's Sarcoma herpesvirus (KSHV), and the inadequate anti-tumoral and anti-viral immune response in the genesis of these malignancies.

The program will highlight basic and translational virologic, immunologic, and genetic research that has promise for the identification and development of targets for diagnosis, prevention, and treatment. It will include topics on laboratory studies, experimental model systems, and therapies for patients. The format will include roundtables, invited lectures, lectures from other registered participants whose abstracts are specifically selected, as well as poster presentations. The participation of NIH-funded investigators with significant new research results is particularly encouraged.

Abstract preparation and submission guidelines, agenda, online registration, and lodging information are available on the Internet. E-mail submission of abstracts is strongly encouraged. The NCI will publish the abstracts in a meeting abstract book and not in the Journal of Acquired Immune Deficiency Syndromes this year.

For additional information please contact: Jaime Quinn, Division of Cancer Treatment and Diagnosis National Cancer Institute; e-mail: jquinn@mail.nih.gov, fax: 301-496-0826; tel.: 301-496-6711.